Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Chugai Pharmaceutical Co. Ltd.
4519Current price
7 046 JPY
-32.58 JPY (-0.47%)
Last closed
7 229 JPY
Company
www.chugai-pharm.co.jp
ISIN
JP3519400000
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Tokyo Stock Exchange
Capitalization
11 875 697 120 435 JPY
Yield for 12 month
+51.43 %
1Y
3Y
5Y
10Y
15Y
4519
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd. Address: 2-1-1 Nihonbashi-Muromachi, Chuo, Japan, 103-8324
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 104 070.08 JPYP/E ratio
30.8192Dividend Yield
1.13 %Current Year
+1 105 855 597 447 JPY
Last Year
+1 253 697 776 256 JPY
Current Quarter
+314 112 514 776 JPY
Last Quarter
+314 344 359 436 JPY
Current Year
+689 572 285 091 JPY
Last Year
+779 808 562 341 JPY
Current Quarter
+230 312 162 015 JPY
Last Quarter
+226 840 464 404 JPY
Key Figures 4519
1 year
3 years
5 years
10 years
EBITDA
564 277 752 817 JPY
Operating Margin TTM
PE Ratio
30.8192
Return On Assets TTM
17.37 %
PEG Ratio
4.4905
Return On Equity TTM
23.2 %
Wall Street Target Price
1 104 070.08 JPY
Revenue TTM
1 136 684 969 509 JPY
Book Value
1 089.29 JPY
Revenue Per Share TTM
Dividend Share
80.6 JPY
Quarterly Revenue Growth YOY
22.4 %
Dividend Yield
1.13 %
Gross Profit TTM
779 808 562 270 JPY
Earnings per share
234.17 JPY
Diluted Eps TTM
234.17 JPY
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
41.1 %
Profit Margin
33.87 %
Dividend Analytics 4519
Dividend growth over 5 years
433 %Continuous growth
2 yearsPayout Ratio 5 years average
44 %Dividend History 4519
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
82
Ex Dividend Date
27.12.2024
Forward Annual Dividend Yield
1.16 %
Last Split Factor
3:1
Payout Ratio
34.44 %
Last Split Date
29.06.2020
Dividend Date
–
Stock Valuation 4519
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
30.8192
Forward PE
28.5714
Enterprise Value Revenue
9.6991
Price Sales TTM
10.0717
Enterprise Value EBITDA
20.4686
Price Book MRQ
6.7908
Financials 4519
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4519
For 52 weeks
4 514.07 JPY
7 829.98 JPY
50 Day MA
6 994.88 JPY
Shares Short Prior Month
–
200 Day MA
5 948.74 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart